Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033093025> ?p ?o ?g. }
- W2033093025 endingPage "916" @default.
- W2033093025 startingPage "910" @default.
- W2033093025 abstract "Recent reports have described different risks of acute myocardial infarction (AMI) in association with specific oral antidiabetic medications. The present study compared the AMI incidence rates in new users of traditional neutral protamine Hagedorn (NPH) insulin and a long-acting synthetic insulin analog for basal insulin therapy. We retrospectively examined in-patient medical claims for AMI in a cohort of oral agent-treated patients with type 2 diabetes mellitus after the initiation of basal insulin therapy with either NPH (n = 5,461) or insulin glargine (n = 14,730) in a national administrative claims database comprising >30 managed healthcare plans in the United States. Poisson regression and Cox proportional hazards regression models, as well as the propensity score methods, were used to compare the subsequent AMI incidence rates after the initiation of NPH or glargine. At a mean follow-up of 2 years, the unadjusted AMI incidence was 17.6/1,000 person-years after the initiation of NPH versus 11.5/1,000 person-years after initiation of glargine (rate ratio 1.53, 95% confidence interval 1.29 to 1.81). The Cox regression model (hazard ratio 1.39, 95% confidence interval 1.14 to 1.69) and sensitivity analyses (hazard ratio range 1.30 to 1.56) showed a greater risk of AMI in the NPH group than in the glargine group. Propensity matched (1:1) analysis yielded similar results (odds ratio 1.55, 95% confidence interval 1.23 to 1.96 for NPH vs glargine). In conclusion, these results suggest that the initiation of basal insulin therapy with NPH rather than glargine in patients with type 2 diabetes mellitus is associated with a greater risk of AMI. Recent reports have described different risks of acute myocardial infarction (AMI) in association with specific oral antidiabetic medications. The present study compared the AMI incidence rates in new users of traditional neutral protamine Hagedorn (NPH) insulin and a long-acting synthetic insulin analog for basal insulin therapy. We retrospectively examined in-patient medical claims for AMI in a cohort of oral agent-treated patients with type 2 diabetes mellitus after the initiation of basal insulin therapy with either NPH (n = 5,461) or insulin glargine (n = 14,730) in a national administrative claims database comprising >30 managed healthcare plans in the United States. Poisson regression and Cox proportional hazards regression models, as well as the propensity score methods, were used to compare the subsequent AMI incidence rates after the initiation of NPH or glargine. At a mean follow-up of 2 years, the unadjusted AMI incidence was 17.6/1,000 person-years after the initiation of NPH versus 11.5/1,000 person-years after initiation of glargine (rate ratio 1.53, 95% confidence interval 1.29 to 1.81). The Cox regression model (hazard ratio 1.39, 95% confidence interval 1.14 to 1.69) and sensitivity analyses (hazard ratio range 1.30 to 1.56) showed a greater risk of AMI in the NPH group than in the glargine group. Propensity matched (1:1) analysis yielded similar results (odds ratio 1.55, 95% confidence interval 1.23 to 1.96 for NPH vs glargine). In conclusion, these results suggest that the initiation of basal insulin therapy with NPH rather than glargine in patients with type 2 diabetes mellitus is associated with a greater risk of AMI. ErratumAmerican Journal of CardiologyVol. 106Issue 4PreviewErratum for Rhoads et al. “Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine” Am J Cardiol 2009;104:910–916 Full-Text PDF" @default.
- W2033093025 created "2016-06-24" @default.
- W2033093025 creator A5017004610 @default.
- W2033093025 creator A5031621111 @default.
- W2033093025 creator A5034671525 @default.
- W2033093025 creator A5046066860 @default.
- W2033093025 creator A5052533254 @default.
- W2033093025 creator A5059551165 @default.
- W2033093025 creator A5083479408 @default.
- W2033093025 date "2009-10-01" @default.
- W2033093025 modified "2023-10-02" @default.
- W2033093025 title "Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine" @default.
- W2033093025 cites W1526927233 @default.
- W2033093025 cites W172609984 @default.
- W2033093025 cites W1866942967 @default.
- W2033093025 cites W1953393606 @default.
- W2033093025 cites W1968865647 @default.
- W2033093025 cites W1973245422 @default.
- W2033093025 cites W1975373497 @default.
- W2033093025 cites W1987941106 @default.
- W2033093025 cites W1990724339 @default.
- W2033093025 cites W1995427842 @default.
- W2033093025 cites W2000445173 @default.
- W2033093025 cites W2015166879 @default.
- W2033093025 cites W2034721698 @default.
- W2033093025 cites W2040851437 @default.
- W2033093025 cites W2083270605 @default.
- W2033093025 cites W2085546759 @default.
- W2033093025 cites W2098512198 @default.
- W2033093025 cites W2121414237 @default.
- W2033093025 cites W2123209921 @default.
- W2033093025 cites W2127125241 @default.
- W2033093025 cites W2129168200 @default.
- W2033093025 cites W2139560478 @default.
- W2033093025 cites W2145397058 @default.
- W2033093025 cites W2151076854 @default.
- W2033093025 cites W2170566445 @default.
- W2033093025 cites W2337454357 @default.
- W2033093025 cites W28542632 @default.
- W2033093025 doi "https://doi.org/10.1016/j.amjcard.2009.05.030" @default.
- W2033093025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19766755" @default.
- W2033093025 hasPublicationYear "2009" @default.
- W2033093025 type Work @default.
- W2033093025 sameAs 2033093025 @default.
- W2033093025 citedByCount "18" @default.
- W2033093025 countsByYear W20330930252012 @default.
- W2033093025 countsByYear W20330930252013 @default.
- W2033093025 countsByYear W20330930252014 @default.
- W2033093025 countsByYear W20330930252015 @default.
- W2033093025 countsByYear W20330930252016 @default.
- W2033093025 countsByYear W20330930252017 @default.
- W2033093025 countsByYear W20330930252022 @default.
- W2033093025 crossrefType "journal-article" @default.
- W2033093025 hasAuthorship W2033093025A5017004610 @default.
- W2033093025 hasAuthorship W2033093025A5031621111 @default.
- W2033093025 hasAuthorship W2033093025A5034671525 @default.
- W2033093025 hasAuthorship W2033093025A5046066860 @default.
- W2033093025 hasAuthorship W2033093025A5052533254 @default.
- W2033093025 hasAuthorship W2033093025A5059551165 @default.
- W2033093025 hasAuthorship W2033093025A5083479408 @default.
- W2033093025 hasConcept C120665830 @default.
- W2033093025 hasConcept C121332964 @default.
- W2033093025 hasConcept C126322002 @default.
- W2033093025 hasConcept C134018914 @default.
- W2033093025 hasConcept C156957248 @default.
- W2033093025 hasConcept C164705383 @default.
- W2033093025 hasConcept C167704817 @default.
- W2033093025 hasConcept C207103383 @default.
- W2033093025 hasConcept C2777180221 @default.
- W2033093025 hasConcept C2779920387 @default.
- W2033093025 hasConcept C44249647 @default.
- W2033093025 hasConcept C500558357 @default.
- W2033093025 hasConcept C50382708 @default.
- W2033093025 hasConcept C555293320 @default.
- W2033093025 hasConcept C61511704 @default.
- W2033093025 hasConcept C71924100 @default.
- W2033093025 hasConceptScore W2033093025C120665830 @default.
- W2033093025 hasConceptScore W2033093025C121332964 @default.
- W2033093025 hasConceptScore W2033093025C126322002 @default.
- W2033093025 hasConceptScore W2033093025C134018914 @default.
- W2033093025 hasConceptScore W2033093025C156957248 @default.
- W2033093025 hasConceptScore W2033093025C164705383 @default.
- W2033093025 hasConceptScore W2033093025C167704817 @default.
- W2033093025 hasConceptScore W2033093025C207103383 @default.
- W2033093025 hasConceptScore W2033093025C2777180221 @default.
- W2033093025 hasConceptScore W2033093025C2779920387 @default.
- W2033093025 hasConceptScore W2033093025C44249647 @default.
- W2033093025 hasConceptScore W2033093025C500558357 @default.
- W2033093025 hasConceptScore W2033093025C50382708 @default.
- W2033093025 hasConceptScore W2033093025C555293320 @default.
- W2033093025 hasConceptScore W2033093025C61511704 @default.
- W2033093025 hasConceptScore W2033093025C71924100 @default.
- W2033093025 hasIssue "7" @default.
- W2033093025 hasLocation W20330930251 @default.
- W2033093025 hasLocation W20330930252 @default.
- W2033093025 hasOpenAccess W2033093025 @default.
- W2033093025 hasPrimaryLocation W20330930251 @default.
- W2033093025 hasRelatedWork W1972702180 @default.